Fabrice Plasson
Vorsitzender bei Amoeba US Corp.
Aktive Positionen von Fabrice Plasson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Amoeba US Corp. | Vorsitzender | - | - |
Entreprise Amoeba Canada, Inc. | Vorsitzender | - | - |
Karriereverlauf von Fabrice Plasson
Ehemalige bekannte Positionen von Fabrice Plasson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AMOÉBA | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 21.07.2010 | 14.12.2023 | |
Vorsitzender | - | 14.12.2023 | |
Gründer | 21.07.2010 | 14.12.2023 | |
Präsident | 21.07.2010 | - | |
EUROFINS DISCOVERX PRODUCTS FRANCE
EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Vorstandsvorsitzender | - | - |
Gründer | - | - | |
Whatman Ltd. | Corporate Officer/Principal | - | - |
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Direktor/Vorstandsmitglied | - | - |
Gründer | - | - | |
Corporate Officer/Principal | - | - |
Ausbildung von Fabrice Plasson
Université Joseph Fourier | Graduate Degree |
EM Lyon Business School | Masters Business Admin |
Statistik
International
Frankreich | 6 |
Vereinigte Staaten | 3 |
Kanada | 2 |
Operativ
Chairman | 3 |
Founder | 3 |
Director/Board Member | 2 |
Sektoral
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMOÉBA | Consumer Non-Durables |
Private Unternehmen | 5 |
---|---|
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Health Technology |
Whatman Ltd. | |
Amoeba US Corp. | |
Entreprise Amoeba Canada, Inc. | |
EUROFINS DISCOVERX PRODUCTS FRANCE
EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Commercial Services |
- Börse
- Insiders
- Fabrice Plasson
- Erfahrung